Affyimmune Therapeutics, Inc., a Natick-based clinical stage biotech company specializing in solid cancer treatment, has named biotech entrepreneur and executive Robert Forrester to its board of directors.
Forrester is a co-founder of Cambridge-based biotech company EQRx, and holds law degrees from University of Bristol and University of Law Guildford in the United Kingdom, according to a Sept. 29 announcement from Affyimmune.
He has served in a variety of executive roles in biotech over the course of two decades, including as chief financial officer, chief operating officer, and CEO, according to Affyimmune.
“It is an honor to join this team and this board as we bring hope to patients facing dire diagnoses with limited treatment options,” Forrester said in a statement. “I have seen firsthand their dedication to excellence, and that is reflected in the expert management team now assembled to lead AffyImmune into the next phase of their clinical and corporate development.”
